Gamgertamig
Gamgertamig is a humanized IgG4 bispecific antibody targeting TNFRSF17 & CD3E[1].
Product Specifications
CAS Number
[3038119-48-8]
UNSPSC
12352100
Target
CD3; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
References & Citations
[1]WHO Drug Information, Vol. 39, No. 2, 2025.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items